Alterity Therapeutics Ownership | Who Owns Alterity Therapeutics?


OverviewForecastChart

Alterity Therapeutics Ownership Summary


Alterity Therapeutics is owned by 2.68% institutional investors, and 97.32% retail investors. Twin lakes capital management is the largest institutional shareholder, holding 1.12% of ATHE shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.01% of its assets in Alterity Therapeutics shares.

ATHE Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAlterity Therapeutics2.68%-97.32%
SectorHealthcare Stocks 42.64%10.86%46.50%
IndustryBiotech Stocks 45.45%10.77%43.78%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Twin lakes capital management139.26K1.12%$428.92K
Morgan stanley63.68K0.60%$196.14K
Hb wealth management58.46K0.47%$180.06K
Greenleaf trust32.00K0.26%$98.56K
Bnp paribas arbitrage, snc6.91K0.06%$21.28K
Acadian asset management4.80K0.04%$14.00K
Rhumbline advisers886.000.01%$3.34K
Gamma investing790.000.01%$2.43K
Advisor group181.000.00%$889.00
Ronald blue trust40.000.00%$123.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Twin lakes capital management139.26K0.19%$428.92K
Hb wealth management58.46K0.00%$180.06K
Greenleaf trust32.00K0.00%$98.56K
Gamma investing790.000.00%$2.43K
Rhumbline advisers886.00-$3.34K
Ronald blue trust40.00-$123.00
Acadian asset management4.80K-$14.00K
Jpmorgan chase---
Bnp paribas arbitrage, snc6.91K-$21.28K
Ubs group---

Top Buyers

HolderShares% AssetsChange
Gamma investing790.000.00%790.00
Rhumbline advisers886.00-756.00
Corecap advisors21.00-21.00
Steward partners investment advisory6.00--
Advisor group181.00--

Top Sellers

HolderShares% AssetsChange
Point72 asset management---131.43K
Ubs group---13.00K
Morgan stanley63.68K--5.00K
Citigroup1.00--635.00
Bnp paribas arbitrage, snc6.91K--400.00

New Positions

HolderShares% AssetsChangeValue
Gamma investing790.000.00%790.00$2.43K
Corecap advisors21.00-21.00$65.00

Sold Out

HolderChange
Sbi securities-1.00
Jpmorgan chase-53.00
Eversource wealth advisors-177.00
Ubs group-13.00K
Point72 asset management-131.43K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20251660.00%334,60250.84%214416276.74%11266.67%2100.00%
Jun 30, 202510-9.09%221,832-8.22%-19527.66%3-50.00%1-
Mar 31, 202510-16.67%235,78189.85%-79104.17%775.00%1-50.00%
Dec 31, 202412-124,19110.22%-50100.00%4-2-
Sep 30, 20241220.00%112,67944.50%-49009.52%4100.00%2100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index1.16K0.01%-

ATHE Ownership FAQ


Who Owns Alterity Therapeutics?

Alterity Therapeutics shareholders are primarily institutional investors at 2.68%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Alterity Therapeutics's industry, Biotech Stocks , is 45.45%, which Alterity Therapeutics falls below.

Who owns the most shares of Alterity Therapeutics?

Alterity Therapeutics’s largest shareholders are Twin lakes capital management (139.26K shares, 1.12%), Morgan stanley (63.68K shares, 0.60%), and Hb wealth management (58.46K shares, 0.47%). Together, they hold 2.18% of Alterity Therapeutics’s total shares outstanding.

Does Blackrock own Alterity Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Alterity Therapeutics.

Who is Alterity Therapeutics’s biggest shareholder by percentage of total assets invested?

Twin lakes capital management is Alterity Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.19% of its assets in 139.26K Alterity Therapeutics shares, valued at 428.92K$.

Who is the top mutual fund holder of Alterity Therapeutics shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Alterity Therapeutics shares, with 0.01% of its total shares outstanding invested in 1.16K Alterity Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools